Fifteen years ago, lung cancer was thought to be one disease. Today, we know there are almost as many types of lung cancer as the individuals who have it. Today’s new precision therapeutics are designed specifically to target and treat these changes in each person’s DNA.
Instead of guessing about which treatment might be most effective, comprehensive genomic testing of your lung tumor or any metastatic solid tumor can, in less than two weeks, simultaneously sequence hundreds of cancer-related genes to provide a full picture of your individual cancer at the molecular level. There is no time for trial and error when you are fighting lung cancer. With unmatched accuracy, comprehensive genomic testing can quickly translate the information inside a tiny tissue sample into a set of potentially more effective and less toxic treatment options that might not otherwise be considered. Ask your doctor about comprehensive genomic testing for your cancer.
The rate at which lung cancer is
diagnosed in the United States.*
* Source: Lung Cancer Research Council
If you and your doctor decide FoundationOne or FoundationACT is right for you, your doctor can order the test. Foundation Medicine will work with your doctor to have your tumor sample sent to our laboratory where it can be examined for genomic alterations. You may have questions about the cost of the test, and whether it is covered by your insurance company. Our FoundationACCESS program can address your financial concerns as well as guide you in accessing targeted therapies and clinical trials identified on your report. Please call Foundation Medicine Client Services at 888-988-3639 if you have any questions and we will be happy to assist you.
Once your tumor sample is received at the Foundation Medicine laboratory, we will extract and sequence DNA from the sample so we can identify genomic alterations. Your physician will receive a detailed report within 14 days from when we receive your sample that contains information about your tumor’s genetic makeup and associated treatment options. These reports are designed to help your physician match your results with available therapies that may treat your specific cancer, as well as any open clinical trials evaluating new targeted treatments. The report is based on up-to-date clinical findings.
Your FoundationOne results may reveal multiple genomic alterations that are driving the growth of your cancer, along with targeted therapies that may be used to treat your cancer. The FoundationOne report also provides information that may indicate if your disease is likely to respond to immunotherapy, a type of medicine which harnesses your immune system to fight your cancer. You and your doctor can evaluate the data available in the context of your unique situation to determine which treatment may be right for you.
You may be a candidate for a clinical trial evaluating a potential new targeted therapy or immunotherapy. Clinical trials are often an important option for patients with cancer, particularly if an approved treatment has stopped working or your cancer has progressed or returned following treatment. Targeted therapies and immunotherapies represent some of the most active areas of cancer research today. Reports include a list of ongoing clinical trials you may be eligible for, and how you and your doctor can find additional studies as they open.